Concepedia

Saurav D. Haldar

SD

Statistics

Publications

5

Citations

176

H-Index

5

Active since

2018

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Sidney Kimmel Comprehensive Cancer Center

Saurav D. Haldar is an author at Johns Hopkins University specializing in oncology, medicine, and neoantigen vaccine combinations.

ORCID

Publications per year

2018–2025

5

Publications

5

Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice

Emma C. Fink, Marie McConkey, Saurav D. Haldar et al. · Blood · 2018 · 127 citations · Full text

, , +4

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Saurav D. Haldar, Thatcher Heumann, Maureen Berg et al. · Journal of Clinical Oncology · 2023 · 16 citations

, , +17

Abstract CT022: Mutant KRAS peptide-based vaccine in patients at high risk of developing pancreatic cancer: Preliminary analysis from a phase I study

Saurav D. Haldar, Amanda L. Huff, Elizabeth Abou Diwan et al. · Cancer Research · 2024 · 12 citations

, , +17

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

Saurav D. Haldar, Carol Judkins, Anna Ferguson et al. · Journal of Clinical Oncology · 2023 · 11 citations

, , +17

Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia

Melissa R. Lyman, Jacob T. Mitchell, Luciane T. Kagohara et al. · JCI Insight · 2025 · 10 citations · Full text

, , +17

1–5 of 5